AUG 17, 2026 · PHASE 1 TRIAL
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)
ClinicalTrials.gov
This is a Phase 1 trial registration with no reported results; it is designed to evaluate safety, tolerability, and proof of mechanism in a small population, and cannot yet inform clinical practice.
Reported
Estimated enrollment32
PhasePhase 1
Primary outcome measure (Part A c…Change from Baseline in [11C]MK-6884 PET BP…